BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 16304985)

  • 21. Long-term outcomes of children treated for Cushing's disease: a single center experience.
    Yordanova G; Martin L; Afshar F; Sabin I; Alusi G; Plowman NP; Riddoch F; Evanson J; Matson M; Grossman AB; Akker SA; Monson JP; Drake WM; Savage MO; Storr HL
    Pituitary; 2016 Dec; 19(6):612-624. PubMed ID: 27678103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No effect of the PPAR-gamma agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo.
    Kreutzer J; Jeske I; Hofmann B; Blumcke I; Fahlbusch R; Buchfelder M; Buslei R
    Clin Neuropathol; 2009; 28(6):430-9. PubMed ID: 19919817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery.
    Danet-Lamasou M; Asselineau J; Perez P; Vivot A; Nunes ML; Loiseau H; San-Galli F; Cherifi-Gatta B; Corcuff JB; Tabarin A
    Clin Endocrinol (Oxf); 2015 Feb; 82(2):260-6. PubMed ID: 24975391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease.
    Rollin G; Ferreira NP; Czepielewski MA
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1355-61. PubMed ID: 18209874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence.
    Petersenn S; Beckers A; Ferone D; van der Lely A; Bollerslev J; Boscaro M; Brue T; Bruzzi P; Casanueva FF; Chanson P; Colao A; Reincke M; Stalla G; Tsagarakis S
    Eur J Endocrinol; 2015 Jun; 172(6):R227-39. PubMed ID: 25599709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary tumor apoplexy in patients with Cushing's disease: endocrinologic and visual outcomes after transsphenoidal surgery.
    Choudhry OJ; Choudhry AJ; Nunez EA; Eloy JA; Couldwell WT; Ciric IS; Liu JK
    Pituitary; 2012 Sep; 15(3):428-35. PubMed ID: 21927887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique.
    Dehdashti AR; Gentili F
    Neurosurg Focus; 2007; 23(3):E9. PubMed ID: 17961027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide.
    Cannavo S; Messina E; Albani A; Ferrau F; Barresi V; Priola S; Esposito F; Angileri F
    Endocrine; 2016 Jun; 52(3):481-7. PubMed ID: 25877016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
    Abellán Galiana P; Fajardo Montañana C; Riesgo Suárez PA; Gómez Vela J; Escrivá CM; Lillo VR
    Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical management of Cushing's disease.
    Dallapiazza RF; Oldfield EH; Jane JA
    Pituitary; 2015 Apr; 18(2):211-6. PubMed ID: 25724315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approach to the postoperative patient with Cushing's disease.
    Rutkowski MJ; Breshears JD; Kunwar S; Aghi MK; Blevins LS
    Pituitary; 2015 Apr; 18(2):232-7. PubMed ID: 25702104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nelson's Syndrome: An Update.
    Fountas A; Karavitaki N
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):413-432. PubMed ID: 32741480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas.
    Petit JH; Biller BM; Yock TI; Swearingen B; Coen JJ; Chapman P; Ancukiewicz M; Bussiere M; Klibanski A; Loeffler JS
    J Clin Endocrinol Metab; 2008 Feb; 93(2):393-9. PubMed ID: 18029460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results and predictors of outcome of endoscopic endonasal surgery in Cushing's disease: 20-year experience of an Italian referral Pituitary Center.
    Guaraldi F; Zoli M; Asioli S; Corona G; Gori D; Friso F; Pasquini E; Bacci A; Sforza A; Mazzatenta D
    J Endocrinol Invest; 2020 Oct; 43(10):1463-1471. PubMed ID: 32215861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Corticotroph adenoma].
    Guignat L; Assie G; Bertagna X; Bertherat J
    Presse Med; 2009 Jan; 38(1):125-32. PubMed ID: 19041214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACTH adenomas transforming their clinical expression: report of 5 cases.
    Zoli M; Faustini-Fustini M; Mazzatenta D; Marucci G; De Carlo E; Bacci A; Pasquini E; Lanzino G; Frank G
    Neurosurg Focus; 2015 Feb; 38(2):E15. PubMed ID: 25639317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
    Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
    J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome.
    Reuss WA; Saeger W; Lüdecke DK
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):395-401. PubMed ID: 1661044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing's disease.
    Netea-Maier RT; van Lindert EJ; den Heijer M; van der Eerden A; Pieters GF; Sweep CG; Grotenhuis JA; Hermus AR
    Eur J Endocrinol; 2006 May; 154(5):675-84. PubMed ID: 16645014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Patients with Nelson's Syndrome after Primary Treatment: A Multicenter Study from 13 UK Pituitary Centers.
    Fountas A; Lim ES; Drake WM; Powlson AS; Gurnell M; Martin NM; Seejore K; Murray RD; MacFarlane J; Ahluwalia R; Swords F; Ashraf M; Pal A; Chong Z; Freel M; Balafshan T; Purewal TS; Speak RG; Newell-Price J; Higham CE; Hussein Z; Baldeweg SE; Dales J; Reddy N; Levy MJ; Karavitaki N
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 31735971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.